InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
7
T+90 hit rate
69%
T+90 mean return
+1.6%
Across 13 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by LAROSA JOSEPH J, Vice-Président Exécutif, Conseiller Juridique et Secrétaire. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 26 disclosures have been recorded. Split: 0 buy · 7 sells. Total volume traded: €9.9m. History available since 2 July 2021. The latest transaction was disclosed on 16 December 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations26 total
●
702 shares@ US$730.811.0% of flowCommon StockSEC:0001883850-24-000062:0
2,332 shares0Common StockSEC:0001968202-24-000135:0
1,866 shares@ US$1,088.953.8% of flowCommon StockSEC:0001968202-24-000107:0
14,450 shares@ US$555.6715.3% of flowCommon StockSEC:0001883850-24-000036:0
1,608 shares0Common StockSEC:0001883850-24-000032:0
1,865 shares@ US$994.903.5% of flowCommon StockSEC:0001968202-24-000096:0
▼
1,000 shares@ US$990.001.9% of flowCommon StockSEC:0001968202-24-000080:0
▼
1,000 shares@ US$967.651.8% of flowCommon StockSEC:0001968202-24-000073:0
▼
1,000 shares@ US$950.001.8% of flowCommon StockSEC:0001968202-24-000058:0
34,000 shares@ US$399.6625.4% of flowCommon StockSEC:0001883850-24-000006:0
●
852 shares@ US$843.791.4% of flowCommon StockSEC:0001968202-23-000052:0
10,000 shares@ US$270.435.1% of flowCommon StockSEC:0001883850-23-000061:0
1,006 shares0Common StockSEC:0001968202-23-000002:0
2,752 shares0Common StockSEC:0001883850-22-000133:0
●
492 shares@ US$753.280.7% of flowCommon StockSEC:0001883850-22-000122:0
30,000 shares@ US$270.4316.6% of flowCommon StockSEC:0001883850-22-000067:0
5,114 shares@ US$721.100.0046% mcap32.2% of flowCommon StockSEC:0001708138-22-000040:0
▼
369 shares@ US$685.710.0003% mcap2.2% of flowCommon StockSEC:0001708138-22-000033:0
●
697 shares@ US$664.340.0006% mcap3.9% of flowCommon StockSEC:0001708138-21-000103:0
●
697 shares@ US$664.340.8% of flowCommon StockSEC:0001708138-21-000103
3,338 shares0Common StockSEC:0001883850-21-000023
3,338 shares0Common StockSEC:0001883850-21-000023:0
10,000 shares@ US$179.130.0021% mcap14.6% of flowCommon StockSEC:0001237899-21-000018:0
10,000 shares@ US$179.133.1% of flowCommon StockSEC:0001237899-21-000018
10,000 shares@ US$179.130.0021% mcap14.4% of flowCommon StockSEC:0001708138-21-000036:0
25 of 26 declarations
About LAROSA JOSEPH J
Joseph J. LaRosa is the EVP General Counsel and Secretary at Regeneron Pharmaceuticals, Inc. He is responsible for overseeing the company's legal affairs and plays a crucial role in managing legal and regulatory risks. His expertise contributes to compliance and the legal strategy of Regeneron.
